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Definition – Early Onset Sepsis
• Sepsis
• Systemic Inflammatory Response Syndrome (SIRS) associated with 
suspected or proven infection
• SIRS – Temp instability, Elevated WBC count or increase I:T ratio, 
Tachycardia or bradycardia, Tachypnea or bradypnea
• Early Onset Sepsis (EOS)
• Sepsis occurring in the first 7 days of life
• Some groups use within first 72 hours 
• National Institute of Child Health and Human Development 
(NICHD), Vermont Oxford Network (VON)
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• 0.23-0.98/1,000 live births 
• High consequence
• 2-4% mortality – much higher in preterm




























• Bacterial infection via
• Vertical transmission – ascending infection
• Contact with mucous membranes
• Transplacental (Listeria)
• Exposure during delivery
• Instrumented delivery, fetal scalp electrode
















• Most common pathogens isolated from blood/CSF
• Group B Strep (GBS) - 38%
• E.Coli – 24%, increasing while GBS decreasing
• Strep viridans – 18%



































• Maternal peripartum invasive strep treatment
• GBS positive + Chorioamnionitis
4-10%
• Chorioamnionitis
• Prolonged rupture of membranes(PROM) + preterm
0.2-1%
• PROM >18 hours
• GBS positive mom
Risk of EOS
• Other maternal factors
• Spontaneous labor <37 
weeks
• Lack of prenatal care
• Meconium stained 
amniotic fluid (MSAF), 
foul smelling fluid
• Other neonatal factors
• Low birth weight (LBW) 
• 5 minute APGAR <5









































• Inflammation limited to the chorion and amnion layers of the fetal 
membranes
• Colloquial
• Inflammation of any intrauterine component
• Clinical
• Clinical suspicion of intra-uterine infection or inflammation
• Fever (approaching fever), foul smelling fluid, maternal/neonatal 
































































• Ascending infection is most 
common
• Severe enough ascending 
infection can infect the fetus 
through contact with mucous 







































• 1-13% of all US births depending upon definition
• Maternal morbidity
• 2-3 fold increase in C-section
• 2-4 fold increase in endomyometritis, wound infection, bacteremia, 
and postpartum hemorrhage
• Neonatal 
• Associated with 40% of cases of EOS
• EOS in 8% of deliveries associated with chorioamnionitis



























• Problem with the definition
• None of the clinical signs/symptoms are specific for the presence of 
chorioamnionitis
• Fever – epidural, dehydration, elevated ambient temperature, prostaglandin 
for induction of labor
• Diagnosis is not standardized but dictates maternal and neonatal care
• Triple I (Intrauterine Infection, Inflammation or Both)
• Standardized approach to diagnosis






































































• Signs and symptoms of EOS are non-specific
• Environmental 
• Temperature instability – low ambient temperature
• Broad non-infectious differential diagnosis
• Prematurity
• Surfactant deficiency, transient tachypnea of newborn
• Metabolic disease
• Cardiac disease
• Maternal medication effects
• Could have non-bacterial cause
• Recovering from intrauterine compromise













• Definitive - positive blood culture or CSF culture
• Suspected - neonates with risk factors and/or clinical indicators for 
neonatal infection
• Treatment needs to be started prior to 
confirmation of infection































1. Identify modifiable prenatal and intrapartum risk factors
2. Intervene prior to delivery
3. Intervene after delivery
vAll before verification of infection   
Identify Modifiable Prenatal Risk Factors
1. Group B Strep (GBS) Colonization
• GBS is the most common cause of EOS
• GBS can be cultured from the vaginal tract 
during pregnancy
2. Chorioamnionitis
GBS – American College of Obstetrics and 
Gynecology (ACOG) Committee Opinion 2019
• Screen all pregnant women for GBS
• Between 36 0/7 and 37 6/7 weeks
• Not necessary if GBS bacteriuria 



























GBS - ACOG Committee Opinion 2019
• Prophylactic antibiotics
• Indications
• Positive GBS cultures – vaginal tract or urine during 
pregnancy
• Previous newborn with GBS disease
• GBS unknown with any of the following:
• Expected preterm birth
• Prolonged rupture of membranes >18 hours
• Maternal fever






























• Cesarean section prior to onset 




• Ideally 4 hours prior to delivery
• Do not delay obstetric 
interventions





PCN Allergy (Not anaphylaxis)
Clindamycin






























Identify and Intervene Prenatally - GBS
• Intrapartum prophylaxis is only current available strategy for EOS
• Universal screening more effective than risk based approach
• Effect of universal screening and intrapartum antibiotic 
prophylaxis on GBS EOS
• 1.8/1000 live births in 1990



































Identify and Intervene Prenatally - Chorioamnionitis
• Identify chorioamnionitis based on local practice
• Triple I standardization at Jefferson
• Initiate targeted antibiotic therapy to limit EOS in baby and 
morbidity in mom
• Plan for delivery
• induction if not in labor
• do not jump to C-section unless clinically indicated for mom
Identify and Intervene Postnatally
• 2010 - Committee on Fetus and Newborn of 
the American Academy of Pediatrics (AAP)
• All babies born to mothers with 
chorioamnionitis
• Blood culture and CBC
• Empiric antibiotics 
• Majority of other babies treated based on 
clinical symptoms/diagnostics
Frieden, T. R. (2009). Morbidity and Mortality Weekly Report 
Prevention of Perinatal Group B Streptococcal Disease. 
Identify and Intervene Postnatally
• Symptoms unreliable
• Risk factors non-specific and multiple
• Diagnostics unreliable or late
• Blood culture only definitive assay – delayed results
• CBC – I:T ratio ≥ 0.2
• Sensitivity 90-100% 



















Identify and Intervene Postnatally
• Wortham et. al 2016
• NICHD 2006-2009 


















v 60-1400 babies treated for 
every 1 baby with EOS 
Identify and Intervene Postnatally
• At Jefferson from 2006-2017 – Following 2010 CDC guidelines
• 6.5% of infants born ≥ 35 weeks gestation were exposed to 
chorioamnionitis
v231 Infants treated with empiric 























Adverse Effects of Early Empiric Antibiotics11-15
• Increased risk for later infection
• Abnormal Immune Programming
• Independent Risk Factor for:
• Asthma, obesity, autoimmune disorders
• Maternal-Infant Separation
• Interfere with breast feeding and bonding
• Prolong hospitalization
• Increased risk of medical error and treatment complications
• Increased Healthcare Cost and Resource Utilization  
Sepsis Risk Calculator
• Developed by Kaiser Permanente
• 350 cases of culture proven EOS in ~600,000 babies ≥ 34 weeks gestation. 
• Took characteristics of the babies with sepsis to develop a risk score 
• Provides guidelines for management based on that risk in this general population 
of neonates
• Not validated in special populations such as chorio
• Spectacular decrease in empiric antibiotic treatment
• From 5% to 2.6% overall

























• Components for preliminary risk
• Maternal temperature 
• Gestational age
• Time elapsed since rupture of membranes
• GBS status
• Type and timing of intrapartum antibiotics
• Prelim risk + clinical status = final risk of EOS 


























• It missed half of the babies with positive BC!!
• They stated that all babies were “caught” before discharge and no 
babies died
• Requires man power, retraining staff, and resources
• Increases chance for miscalculation and holding antibiotics
• Survey of 682 members of AAP
• 169 (25%) Use calculator for CHORIO babies




















• Jefferson Chorioamnionitis/Sepsis Risk Calculator Study
• We looked at 1029 babies exposed to Chorio
• Calculated EOS risk for 688
• 74% of the babies qualified for observation or limited eval without 
empiric antibiotics!
• But that included 2 out of 5 culture positive babies




















American Academy of Pediatrics (AAP) Guidelines 2018
• ≥35 0/7 Weeks Gestation
• Three distinct approaches
1. Categorical risk assessment – Empiric antibiotics for all “Chorio” 
babies
2. Multivariate risk assessment – Sepsis risk calculator 
3. Enhanced observation/based on clinical condition – Increased 
monitoring/lab eval
v“Each approach has merits and limitations, and each is a 
reasonable approach to risk assessment among infants who are 











































• Distinct risk assessment and approach for ≥35 weeks 
gestation
• Three reasonable approaches
• Local guidelines should be developed
• EOS is diagnosed by positive blood or CSF cultures, not 






















• When Blood cultures are sterile, antibiotics should be discontinued by 
36 to 48 hours unless there is evidence of site specific infection
• Persistent cardiorespiratory instability is common among preterm 
infants with very low birth weight babies and is not alone an 
indication for prolonged empirical antibiotics
• Laboratory test abnormalities alone rarely justify prolonged 
empirical antibiotics administration, especially among preterm 





















• What is the problem?
• What is occurring OR What are we missing?
• Overtreatment with empiric antibiotics despite increasing 
knowledge of adverse affects and new AAP guidelines 
• When did the problem start?
• 10+ years – as far back as 2006
• Where is the problem taking place?
• The Jefferson Intensive Care Nursery
• Extent (Gap) of the problem or opportunity
• 1159 neonates ≥35 weeks gestation were treated from 2006-2017
• Only 5 of those had culture proven early onset sepsis
Problem Statement
• All neonates born in 2018 in our NICU that were exposed to 
chorioamnionitis were treated with empiric antibiotics 
despite their relatively low risk for EOS and increasing 
knowledge of the possible adverse affects of antibiotics
Jefferson Intensive Care Nursery (ICN) Characteristics
• 40+ Bed
• Level III
• Multiple ventilator types
• Preemies down to 22 weeks gestation
• Complex medical conditions
• Not so complex surgical conditions
• No ECMO or cardiac surgery (Level IV)
• Typical patients - prematurity, neonatal abstinence, infection











Previous Antibiotic Stewardship Project
Jefferson EOS Antibiotic 
Stewardship Guideline
Prior 2018
• All chorio exposed babies 
receiving antibiotics
• Standardized approach focused 
on limiting extension of empiric 
antibiotics
• Probably decreased overall 
antibiotic treatment length
Our Project
• New AAP Guidelines 
• Jefferson clinical research on EOS







High Level Project Plan
1. Smart Aim
2. Stakeholder analysis








• Specific Measurable Attainable Relevant Time-Bound
• Decrease empiric antibiotic usage by 50% within 1 year 
of initiation in those infants exposed to 
chorioamnionitis and born at ≥ 35 weeks gestation
Stakeholder Analysis - ICN


































Issues/ Concerns Influence Strategy
Neonatologists X • Missed cases of EOS
• Decline in census
• Review data
• Review proposal with increased 
monitoring in nursery
Neonatal Nurses X • Missed cases of EOS
• Decline in procedural 
experience (PIV placement)
• Decline in census
• Same as above
• Review newest guidelines
• Still admitting for initial screening
Neonatal 
Fellows/NNPs
X • Missed cases of EOS
• Decline in procedural 
experience
• Review data
• Review proposal with increased 
monitoring in nursery
ICN Nurse Manager X • Decline in census
• Decline in procedural 
experience
• Review newest guidelines
• Still admitting for initial screening
Division Chief X • Missed cases of EOS • Review data
• Review proposal with increased 
monitoring in nursery
ICN Charge Nurses X • Difficulty managing nurse 
assignments with increased 
patient turnover
• Decline in census
• Still admitting for initial screening
• Standardize sign our and patient flow 
between ICN and pediatrics
Stakeholder Analysis - ICN
• Concerns
• Would we miss cases of EOS?
• Would we see a decline in census?
• Would we see a decline in procedural competence 
(Blood draws, peripheral IV placement, Lumbar 
Puncture)?
• How would we handle the patient turnover?
Stakeholder Analysis – Outside ICN


































Issues/ Concerns Influence Strategy
Pediatricians X • Missed cases of EOS/sicker 
babies in nursery
• Increased patient load
• Review data
• Standardize screening/management
Pediatric Residents X • Sicker babies in nursery




Post partum nurses X • Sicker babies in nursery




• Neonatal staff readily available 
overnight
Pharmacy X • Missed cases of EOS
• Decreased medication 
administration
• Review data
• Review newest guidelines
Obstetricians X • Missed cases of EOS • Review data
• Standardize screening/management
Parents X • Missed cases of EOS • Review data in real time
• Standardize screening/management
Stakeholder Analysis – Outside ICN
• Concerns
• Would we have sicker babies in term nursery?
• Would we see an increase in census?
• How would we handle the patient turnover, new 
workload?
• Pediatricians no longer in house over night
Stakeholder Analysis - Everyone
• Excited for the change
• Long time coming
• Many units admit these babies to nursery
• Many using early onset sepsis calculator for years
• Keeping mom and baby together for longer
• Possibly improve breast feeding
• Give less antibiotics
Current State 
Prior to 2018
• All chorio exposed = Blood 
culture + empiric antibiotics
• Standardize length of therapy 






to ICN for at least 
36 hours




at 12 hours of life
LP Performed if 
CBC/CRP/Blood 
culture abnormal
ICN stay extended 




• ~100 babies admitted with chorioamnionitis per year
• 100% of those babies receive antibiotics for at least 48 hours
• Ampicillin and Gentamicin
• All of those babies spend at least 36-48 hours in the ICN
• Separated from mother
• Arterial blood sampling for blood culture, heel stick for 
CBC/CRP
• IV access obtained – peripheral, umbilical, PICC
Driver Diagram
PRIMARY DRIVERS SECONDARY DRIVERS
Decrease empiric antibiotic usage by 
50% within 1 year of initiation in those 
infants exposed to chorioamnionitis 




• In person didactic with Neonatologists
• In person didactic with ICN leaders
• Powerpoint for ICN, nursery, and OB staff
• In person discussion with pediatricians
• Develop new guidelines based on clinical 
research at Jeff and AAP guidance
• PDSA cycles to tighten guidelines 
• Adjust guidelines based on latest research
• Continued research on EOS calculator utility





with nursery and OB
• Optimize DR care with no empiric abx
• Develop plan for transfer from ICN to nursery 
after sepsis screening
AAP/COFN 2018 Guidelines
New Jefferson EOS Management Guideline
• ≥35 0/7 Weeks Gestation
• Hybrid of 3 approaches
1.Sick - Treat
2.Chorio – Observe 12 hours in ICN, blood culture, calculator,
and CBC/CRP
3.GBS – Increased vitals, watch at least 48 hours
4.ROM >18 - Increased vitals, watch at least 48 hours








• Initial guideline implemented with CBC/CRP 
• Abnormal would require antibiotic administration for remainder of 48 
hours of blood culture
• Study
• Repeated insistence by AAP that CBC/CRP should not dictate antibiotic 
treatment in well appearing baby
• No missed cases of EOS for 8 months
• Act
• Second guideline produced with CBC/CRP removed









Birth Weight, mean (SD), g 3342 (413) 3383 (426) 0.48
Gestational Age, mean (SD), wk 39.3 (1.1) 39.1 (1.2) 0.18
Male, n (%) 48 (48) 60 (53) 0.58
SGA (<10th percentile) 8 (8) 4 (4) 0.23
African American race, n (%) 28 (28) 33 (29) 1.00
C-section 27 (27) 40 (35) 0.24
Results
Characteristic Before After P-value
Empiric Antibiotic, n (%) 99 (100) 38 (34) <.0001
Antibiotic Days (/100 Infants) 231 (233) 91 (80)
• 34% of previous antibiotic use per baby (3x less)
• 34% of the previous antibiotic days (3x less)
Run Chart












































































Before PDSA #1 PDSA #2
Run Chart






























































































Before PDSA #1 PDSA #2
Healthcare Cost
• General Healthcare
• ~100 chorio babies per year from 2006-2017
• Potential to cut ICU length of stay for chorio babies from 2 to 1 day
• Decrease of 100 ICU days
• Decrease lifetime cost related to antibiotic exposure
• Allergy, asthma, obesity, benefits of breast milk
• Jefferson
• Insurance companies increasingly not paying for ICU level for exposure to 
chorioamnionitis
• Improve breast feeding success, decrease mother-infant separation 
Communication Plan
Group Key Message Delivery Mechanism(email/ phone/ etc.) Frequency
Person Responsible to 
Deliver
Neonatologists Safely limiting abx exposure and separating 
mother/infant less 
Email, attending meeting Every 6 months Me
Neonatal Nurses Safely limiting abx exposure and separating 
mother/infant less 
Email, dashboard Every 6 months, 
monthly
Me
Neonatal Fellows Safely limiting abx exposure and separating 
mother/infant less 
Email, dashboard Every 6 months, 
monthly
Me
ICN Nurse Manager Safely limiting abx exposure and separating 
mother/infant less, cutting costs 
Email, dashboard, Quality and 
Safety meeting






Safely decreasing mother/infant separation, 
improving mother/infant bonding/availability
for breast feeding
EOS Case Review, Email As needed, 6 months Me
Parents Safely limiting abx exposure, less separation, 
lower bill




• EOS Calculator Incorporated into EPIC
• Blood culture from umbilical cord rather than baby
• Limit interventions
• Set up for eventual admission directly to nursery from DR
• Evaluate Impact on mother-infant separation, breastfeeding 
success
• Skip the ICN altogether
Questions?
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